Liver transplantation after radioembolization in a patient with unresectable HCC

Nature Reviews Gastroenterology and Hepatology

Volumn 6, Issue 11, 2009, Pages 679-683

  Luna, Laura E Moreno ^a   Kwo, Paul Y ^c   Roberts, Lewis R ^b   Mettler, Teresa A ^b   Gansen, Denise N ^b   Andrews, James C ^b   Wiseman, Gregory A ^b   Misra, Vijay Laxmi ^c  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b MAYO CLINIC   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RADIOACTIVE MICROSPHERE; RITUXIMAB; STEROID; TACROLIMUS; YTTRIUM 90;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CANCER RADIOTHERAPY; CASE REPORT; DRUG MEGADOSE; HUMAN; INOPERABLE CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; NONALCOHOLIC FATTY LIVER; PORTAL HYPERTENSION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; YTTRIUM RADIOISOTOPES;

EID: 71049177368     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2009.165     Document Type: Article

References (19)

1. Howe, H. L. et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl Cancer Inst. 93, 824-842 (2001).
2. El-Serag, H. B. & Mason, A. C. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340, 745-750 (1999).
3. El-Serag, H. B. et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update. Ann. Intern. Med. 139, 817-823 (2003).
4. Altekruse, S. F. et al. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J. Clin. Oncol. 27, 1485-1491 (2009).
5. Alberts, S. R. et al. Treatment options for hepatobiliary and pancreatic cancer. Mayo Clin. Proc. 82, 628-637 (2007).
6. Bruix, J. & Sherman, M. Management of hepatocellular carcinoma. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Hepatology 42, 1208-1236 (2005).
7. Fung, J. & Marsh, W. The quandary over liver transplantation for hepatocellular carcinoma: The greater sin? Liver Transpl. 8, 775-777 (2002).
8. Mazzaferro, V. et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 334, 693-699 (1996).
9. Yao, F. Y. et al. Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl. 8, 765-774 (2002).
10. Yao, F. Y. et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 33, 1394-1403 (2001).
11. Goin, J. E. et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: Factors associated with liver toxicities. J. Vasc. Interv. Radiol. 16, 205-213 (2005).
12. Kulik, L. M. et al. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation. J. Surg. Oncol. 94, 572-586 (2006).
13. Salem, R. & Hunter, R. D. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: A review. Int. J. Radiat. Oncol. Biol. Phys. 66, S83-S88 (2006).
14. Geschwind, J. F. et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127, S194-S205 (2004).
15. Salem, R. et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): Safety, tumor response, and survival. J. Vasc. Interv. Radiol. 16, 1627-1639 (2005).
16. Moreno-Luna, L. E. et al. The clinical value of radioembolization in the treatment of inoperable liver cancer. US Gastroenterology & Hepatology Review 4, 32-36 (2009).
17. Carr, B. I. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients. Liver Transpl. 10, S107-S110 (2004).
18. Bruix, J. & Llovet, J. M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35, 519-524 (2002).
19. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 28, 751-755 (1998).